Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura [EARLY_Phase 1]
Phase 1 study evaluating rituximab plus prednisone as first-line therapy for immune thrombocytopenia has been completed.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. [Phase 3]
Phase 3 trial in children with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) evaluating a new medication has completed. Resu…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP [Phase 2]
Phase 2 trial update reporting results of rapid intravenous immunoglobulin (IVIG) infusion in patients with immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
Phase 2 trial completed evaluating fostamatinib disodium (R935788) for adult patients with refractory immune thrombocytopenia (ITP). Results…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults [Phase 3]
Phase 3 clinical trial evaluating Octagam 10% for immune thrombocytopenia in adults has completed. Results were posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
A completed trial update evaluating Nexium (esomeprazole) for Helicobacter pylori–specific clinical experience across several gastric diseas…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Rituximab as Second Line Treatment for ITP [Phase 3]
Phase 3 clinical trial evaluating rituximab as second-line treatment for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
A completed clinical trial evaluating health-related quality of life and fatigue in adults with primary immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT [Phase 2]
This report covers a Phase 2 trial evaluating eltrombopag with high-dose dexamethasone as first-line therapy for immune thrombocytopenia. Th…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects [Phase 1]
Phase 1 study to evaluate the relative bioavailability and intra-subject variability of two lots of E5501 40 mg tablets in healthy subjects …
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Immunoglobulins Anti Platelets In Breast Milk Of Maternal ITP
This is a clinical trial update evaluating immunoglobulins targeting platelets in the breast milk of mothers with immune thrombocytopenia (I…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
A Phase 2 trial evaluating SB-497115, an oral thrombopoietin receptor agonist, versus placebo in adults with refractory immune thrombocytope…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of maintenance treatment with recombinant human thrombopoietin (rhTPO) in patients…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia [Phase 2, Phase 3]
An update on a Phase 2/Phase 3 clinical trial evaluating the effect of an antioxidant on oxidant status in immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2012-11-15Clinical Trial Update: Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
This completed trial compared a fixed-dose rituximab schedule (1000 mg on days 1 and 15) with the standard regimen in adults with primary im…
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura [NA]
This completed clinical trial update examines vaccine response following rituximab treatment in patients with chronic, severe immune thrombo…
-
CLINICAL_TRIALS trial_result · 2012-10-23Clinical Trial Update: Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia
This update reports the efficacy results of a completed trial evaluating all-trans retinoic acid as an immunomodulatory therapy for adults w…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
This document reports on a completed clinical trial evaluating the efficacy of rapamycin therapy in patients with chronic immune thrombocyto…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety.
This completed clinical trial compared alternating use of eltrombopag and romiplostim in immune thrombocytopenia and reported on efficacy an…
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP) [Phase 2]
This document reports the completion of a Phase 2 pilot trial evaluating Rituximab for the treatment of acute immune thrombocytopenic purpur…
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [Phase 1]
Phase 1 pharmacokinetic variability study evaluating two lots of E5501 administered to fed and fasted healthy subjects.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 [Phase 3]
A Phase 3 trial evaluating Intravenous Immunoglobulin IgPro10 for immune thrombocytopenia has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-06Clinical Trial Update: Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 3]
Open-label extension of romiplostim in patients with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) in a Phase 3 study; the t…
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects [Phase 1, Phase 2]
Phase 1/2 study evaluating safety and efficacy of romiplostim in pediatric idiopathic thrombocytopenic purpura completed; results posted in …
-
CLINICAL_TRIALS trial_result · 2010-07-15Clinical Trial Update: Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 trial evaluating a combination of Helicobacter pylori eradication, Anti-D immunoglobulin, and danazol for steroid-dependent or refra…